Acta paediatrica (Oslo, Norway : 1992) · 2026
Paediatric Healthcare Utilisation Trends From the Pre-Pandemic Period Through Two Years Post-COVID-19: Evidence From a Nationwide Big-Data Analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shmueli Einat, Gutman Elite, Levy Joseph, Sagiv Maya, Wygoda Noam, Levine Hagit, Stafler Patrick, Rothschild Benjamin, Mei-Zahav Meir, Prais Dario, Bar-On Ophir
Аннотация
AIM: The COVID-19 pandemic was associated with a marked decline in respiratory infections and asthma exacerbations in children. Following the easing of restrictions, a rebound in respiratory morbidity was observed. However, the long-term impact on paediatric asthma remains unclear.
METHODS: We conducted a retrospective study using data from the largest healthcare provider in Israel. Children aged 2-18 years with recurrent wheezing or clinician-diagnosed asthma were included. Healthcare utilisation between January 2019 and July 2023 was analysed.
RESULTS: A total of 209 954 children, mean age 6.8 years (56.9% male), were included. During winter 2020-2021, compared with winter 2019-2020, healthcare utilisation declined significantly for chest radiographs (CXR) (RR = 0.69), asthma medication dispensing (RR = 0.67), and emergency department (ED) visits (RR = 0.61). After restrictions were lifted, all outcomes rose sharply, peaking in summer 2021. By winter 2022-2023, rates of CXR (RR = 1.30), asthma medication dispensing (RR = 1.03), ED visits (RR = 1.04), and hospitalisations (RR = 1.30) remained significantly higher than pre-pandemic levels across all age groups.
CONCLUSION: Paediatric respiratory-related healthcare utilisation exceeded pre-pandemic levels during the first and second post-pandemic winters. These findings highlight the unpredictable, long-lasting, and indirect consequences of pandemic-era interventions on respiratory health.
METHODS: We conducted a retrospective study using data from the largest healthcare provider in Israel. Children aged 2-18 years with recurrent wheezing or clinician-diagnosed asthma were included. Healthcare utilisation between January 2019 and July 2023 was analysed.
RESULTS: A total of 209 954 children, mean age 6.8 years (56.9% male), were included. During winter 2020-2021, compared with winter 2019-2020, healthcare utilisation declined significantly for chest radiographs (CXR) (RR = 0.69), asthma medication dispensing (RR = 0.67), and emergency department (ED) visits (RR = 0.61). After restrictions were lifted, all outcomes rose sharply, peaking in summer 2021. By winter 2022-2023, rates of CXR (RR = 1.30), asthma medication dispensing (RR = 1.03), ED visits (RR = 1.04), and hospitalisations (RR = 1.30) remained significantly higher than pre-pandemic levels across all age groups.
CONCLUSION: Paediatric respiratory-related healthcare utilisation exceeded pre-pandemic levels during the first and second post-pandemic winters. These findings highlight the unpredictable, long-lasting, and indirect consequences of pandemic-era interventions on respiratory health.